Prestige Biopharma

NCT03390686

Phase 3, Active, not recruiting, 2019, 650 people, 4 Jan 2018, clinicaltrials.gov

NCT03013504

Phase 3, Completed, 2018, 503 people, 6 Jan 2017, clinicaltrials.gov